[Home]   [Full version]  

Some vindication for S. Korean scientist?

Mar 13 ,General Science



Full size image
A South Korean who worked with Hwang Woo-Suk, the scientist accused of faking results, says their claim to have cloned stem cells will be vindicated.

Professor Kang Sung-keun of Seoul National University told the Korea Times that tests show a stem cell line featured in their report in Science has genetic material from two parents. A university panel found that Stem Cell Line No. 1 was created from an unfertilized egg.

The panel found signs that the cells' genetic material did not match the original donor.

"The university may have made an error, as such phenomenon can happen in cancerous cells, which share a lot of characteristics with stem cells," Kang said. "That means that the cell line may indeed be a cloned but damaged one.".

Hwang has already enjoyed a measure of vindication. A report last week in Nature said that Snuppy, claimed by Hwang to be the first cloned dog, is the real McCoy.

Hwang's claim to have developed patient-specific stem cells has been determined to be fraudulent.

Copyright 2006 by United Press International

Related stories:

Mapping brain cancer to find best treatment
There's never a good time to have brain cancer. Still, Karl DuBose tries to look on the bright side. "It's weird to say, but today - and here in Seattle - might be the best time and place to get this disease," said the 45-year-old Everett, Wash., man, who was slammed with the diagnosis last summer.
Stem cell obstacles
"There are still a number of major hurdles in the path of stem cell research today that are preventing the routine application of the technology in regenerative medicine." So say UK scientists writing in a forthcoming issue of the International Journal of Biotechnology.
Where does the gene activity of youth go? New findings may hold the key
New evidence may explain why it is that we lose not only our youthful looks, but also our youthful pattern of gene activity with age. A report in the November 26th issue of the journal Cell, a Cell Press publication, reveals that a protein perhaps best known for its role in the life-extending benefits of a low-calorie diet also maintains the stability of the mammalian genome—the complete set of genetic instructions "written" in DNA.
Kidney function discovery sheds light on genetic complexity of disease
To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.
Scientists achieve repair of injured heart muscle in lab tests of stem cells
Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue.
'Embryo adoption' service seeks to give infertile couples a chance to have a family
The day the frozen embryo arrived via FedEx was the day Maria Lancaster began experiencing firsthand what she had always believed: that human life begins at conception.
Researchers investigate how plants adapt to climate
(PhysOrg.com) -- How many mouths does a plant need in order to survive? The answer changes depending on climate, and some of the decisions are made long before a new leaf sprouts.
Physicists Receive Patent for Improved Cancer Therapy Device
Four physicists at the U.S. Department of Energy's Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a “medical synchrotron” capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue. The new device would be more precise and less costly than existing proton-therapy systems, potentially increasing the availability and benefits of this treatment for cancer patients worldwide. The Brookhaven scientists are now seeking industrial partners to license and commercialize the technology.

News discussion:

General Science news

[Home]   [Full version]